Mindray Medical International Limited is a developer, manufacturer and marketer of medical devices across the world. The Company operates in three segments: patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. Its patient monitoring devices track the physiological parameters of patients, such as heart rate, blood pressure, respiration and temperature. It offers patient monitoring devices that are suitable for adult, pediatric and neonatal patients and are used principally in hospital intensive care units, operating rooms and emergency rooms. Its life support products provide operation room or intensive care unit solutions for the end users in the operating room. Its in-vitro diagnostic products provide data and analysis on blood, urine and other bodily fluid samples for clinical diagnosis and treatment. Its medical imaging systems segment includes ultrasound systems, digital radiography systems and a magnetic resonance imaging system.
Industry, Sector and Symbol:
- 50 Day Moving Avg: $27.20
- 200 Day Moving Avg: $25.81
- 52 Week Range: $21.80 - $33.83
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 15.97
- P/E Growth: 0.00
- Net Margins: 15.93%
- Return on Equity: 12.70%
- Return on Assets: 8.37%
- Average Volume: 965,593 shs.
Frequently Asked Questions for Mindray Medical International Ltd (NYSE:MR)
What is Mindray Medical International Ltd's stock symbol?
Mindray Medical International Ltd trades on the New York Stock Exchange (NYSE) under the ticker symbol "MR."
How were Mindray Medical International Ltd's earnings last quarter?
Mindray Medical International Ltd (NYSE:MR) announced its quarterly earnings data on Friday, November, 13th. The company reported $0.51 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.32 by $0.19. The firm earned $327.60 million during the quarter. Mindray Medical International Ltd had a return on equity of 12.70% and a net margin of 15.93%. During the same quarter in the previous year, the firm posted $0.47 EPS. View Mindray Medical International Ltd's Earnings History.
Who are some of Mindray Medical International Ltd's key competitors?
Some companies that are related to Mindray Medical International Ltd include Thermo Fisher Scientific (TMO), Danaher Corporation (DHR), Boston Scientific Corporation (BSX), Koninklijke Philips N.V. (PHG), Intuitive Surgical (ISRG), Illumina (ILMN), Edwards Lifesciences Corporation (EW), Cerner Corporation (CERN), Agilent Technologies (A), Waters Corporation (WAT), ResMed (RMD), Hologic (HOLX), Varian Medical Systems (VAR), PerkinElmer (PKI), ABIOMED (ABMD), Bruker Corporation (BRKR), Alere (ALR) and Quidel Corporation (QDEL).
How do I buy Mindray Medical International Ltd stock?
Shares of Mindray Medical International Ltd can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Mindray Medical International Ltd's stock price today?
MarketBeat Community Rating for Mindray Medical International Ltd (NYSE MR)MarketBeat's community ratings are surveys of what our community members think about Mindray Medical International Ltd and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Mindray Medical International Ltd stock can currently be purchased for approximately $27.94.
Consensus Ratings for Mindray Medical International Ltd (NYSE:MR) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Mindray Medical International Ltd (NYSE:MR)
(Data available from 9/21/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|11/13/2015||Standpoint Research||Reiterated Rating||Buy -> Hold||N/A|
|10/23/2015||Deutsche Bank AG||Downgrade||Buy -> Hold||$30.00 -> $27.00||N/A|
Earnings History for Mindray Medical International Ltd (NYSE:MR)Earnings History by Quarter for Mindray Medical International Ltd (NYSE MR)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|8/10/2015||Q215||$0.43||$0.42||$360.50 million||$336.80 million||View||Listen|
|5/11/2015||Q1||$0.38||$0.33||$288.50 million||$272.50 million||View||Listen|
|3/9/2015||Q4||$0.52||$0.50||$407.07 million||$399.00 million||View||Listen|
|11/3/2014||Q314||$0.43||$0.43||$334.50 million||$324.60 million||View||Listen|
|5/5/2014||Q114||$0.37||$0.50||$292.50 million||$264.80 million||View||Listen|
|3/3/2014||Q413||$0.50||$0.62||$351.26 million||$368.40 million||View||Listen|
|8/5/2013||Q2 2013||$0.47||$0.56||$312.06 million||$307.20 million||View||Listen|
|5/6/2013||Q1 2013||$0.41||$0.53||$254.97 million||$242.10 million||View||Listen|
|2/25/2013||Q4 2012||$0.39||$0.51||$309.30 million||$316.10 million||View||Listen|
|11/5/2012||Q312||$0.41||$0.42||$260.02 million||$257.10 million||View||N/A|
Earnings Estimates for Mindray Medical International Ltd (NYSE:MR)
Current Year EPS Consensus Estimate: $1.54 EPS
Next Year EPS Consensus Estimate: $1.75 EPS
Current Dividend Information for Mindray Medical International Ltd (NYSE:MR)
|Most Recent Dividend:||3/31/2015|
|Dividend Growth:||0.00% (3 Year Average)|
|Payout Ratio:||0.00% (Based on This Year's Estimates)|
0.00% (Based on Next Year's Estimates)
Dividend History by Quarter for Mindray Medical International Ltd (NYSE MR)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading History for Mindray Medical International Ltd (NYSE:MR)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Mindray Medical International Ltd (NYSE:MR)
Latest Headlines for Mindray Medical International Ltd (NYSE:MR)
Mindray Medical International Ltd (MR) Chart for Thursday, September, 21, 2017